Drug Approval | January 21, 2022
Medicines Patent Pool finalises 27 generic manufacturers to produce molnupiravir
The drug is to be supplied in 105 low and middle-income countries and 10 Indian firms are on the list
The drug is to be supplied in 105 low and middle-income countries and 10 Indian firms are on the list
ASC10 is an oral direct-acting antiviral drug candidate targeting RNA dependent RNA polymerase (RdRp) to treat SARS-CoV-2 infection
The contract award from the U.S. Department of Defense (DoD), on behalf of the U.S. Department of Health and Human Services, is part of an effort to ensure secure local supply and production capacity for critical products for pandemic preparedness
Rapid antigen testing provides results in just 15 minutes and the information can help reduce the risk of Covid-19 exposure
This is the fourth facility from the company to receive this registration
Betting big on talent, resources, and the ecosystem required for innovation and enterprise, Prime Minister Narendra Modi invited stakeholders to ideate in India, innovate in India and Make in India for the world
The US $ 192.5 mn US government contract will help fund the centre of excellence to boost the domestic supply of critically needed laboratory plastics
It is the world’s first DNA-based Covid vaccine
The new manufacturing facility will be built at a subsidiary of Adcock Ingram and will commence operation in March 23
The release of this batch will secure the supply for hospitals and cancer centres that are involved in the clinical trials managed by the company
Subscribe To Our Newsletter & Stay Updated
